By Steven Reinberg
HealthDay Reporter
MONDAY, Feb. 27 (HealthDay News) — Many people with stable heart disease undergo an expensive artery-opening procedure when medication would work just as well, a new study suggests.
The procedure involves placing a tiny mesh stent, or tube, in a clogged artery. As many as three-quarters of these operations are unnecessary, said lead researcher Dr. David L. Brown, a professor of medicine at Stony Brook University Medical Center in New York.
By Serena Gordon
HealthDay Reporter
TUESDAY, Jan. 24 (HealthDay News) — Children with asthma who don’t have heartburn and other signs of gastroesophageal reflux don’t get additional asthma control from acid-reducing medications, according to new research.
And, taking these medications when there are no digestive issues increases a child’s risk of developing a respiratory infection, reports the study.
THURSDAY, Jan. 5 (HealthDay News) — Susan Schneck began suffering from frequent, painful heartburn in 1998.
By Dennis Thompson
HealthDay Reporter
“In the evening and especially after lying down to go to sleep, I would invariably experience heartburn,” Schneck said. “It was a burning. Not exactly nausea, but that same type of upward sensation, only with that burning. Like you’d had a hot drink or really, really spicy food. And once it started, it wouldn’t go away.”
By Maureen Salamon
HealthDay Reporter
MONDAY, May 9 (HealthDay News) — Reinforcing U.S. health officials’ concerns, new Korean research suggests that long-term use of popular heartburn drugs such as Prilosec, Prevacid and Nexium is linked to an increased risk of fractures.
Scientists conducting a meta-analysis of 11 studies published between 1997 and 2011 found that proton pump inhibitors (PPIs), which reduce stomach acid production, were associated with a 29 percent increased risk of fracture. This included a 31 percent higher risk of hip fractures and a 54 percent heightened risk of vertebral fractures.
By Jenifer Goodwin
HealthDay Reporter
MONDAY, Dec. 20 (HealthDay News) — Popular heartburn drugs, including proton pump inhibitors and histamine-2 receptor antagonists, may raise the risk of pneumonia, new research finds.
Researchers in Korea analyzed the results of 31 studies on heartburn drugs published between 1985 and 2009.
By Ellin Holohan
HealthDay Reporter
FRIDAY, Dec. 17 (HealthDay News) — Contrary to popular belief, acid reflux disease, better known as heartburn, is not much of a risk factor for esophageal cancer for most people, according to new research.
“It’s a rare cancer,” said study author Dr. Joel H. Rubenstein, an assistant professor in the University of Michigan department of internal medicine.
By Amanda Gardner
HealthDay Reporter
WEDNESDAY, Nov. 24 (HealthDay News) — Babies born to women who took a popular class of heartburn drugs while they were pregnant did not appear to have any heightened risk of birth defects, a large Danish study finds.
This class of drugs, known as proton-pump inhibitors (PPIs), include blockbusters such as Prilosec (omeprazole), Prevacid (lansoprazole) and Nexium (esomeprazole). All were available by prescription-only during most of the study period (1996-2008), but Prilosec and Prevacid are now sold over-the-counter.
By Steven Reinberg
HealthDay Reporter
WEDNESDAY, Oct. 6 (HealthDay News) — Heartburn drugs known as proton-pump inhibitors can safely be taken with the blood thinner Plavix, a new study indicates.
There has been concern that these medications, called PPIs, might interfere with the ability of Plavix (clopidogrel) to do its job.
MONDAY, Sept. 20 (HealthDay News) — The intravenous administration of aspirin appears to be a safe and effective way to treat hospitalized patients suffering from either severe headaches or migraines, new research indicates.
Study author Dr. Peter J. Goadsby, of the Headache Group in the department of neurology at the University of California, San Francisco, described his team’s findings in the Sept. 21 issue of Neurology.
By Steven Reinberg
HealthDay Reporter
TUESDAY, May 25 (HealthDay News) — Blockbuster heartburn medications such as Prevacid, Prilosec and Nexium will now carry a warning on their labels linking the drugs to a heightened risk for fractures, the U.S. Food and Drug Administration announced late Tuesday.
The label will advise consumers to use this class of medicines, called proton pump inhibitors (PPIs), carefully, because high doses have been associated with an increased risk of fractures of the hip, wrist and spine, the agency said.
| Text Size: |  |
|
